Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies

Transplantation

Volumn 51, Issue 2, 1991, Pages 443-447

  Beatty, Patrick G ^a   Hansen, John A ^a   Longton, Gary M ^a   Thomas, E Donnall ^a   Sanders, Jean E ^a   Martin, Paul J ^a   Bearman, Scott I ^a   Anasetti, Claudio ^a   Petersdorf, Effie W ^a   Mickelson, Eric M ^a   Pepe, Margaret S ^a   Appelbaum, Fredrick R ^a   Buckner, C Dean ^a   Clift, Reginald A ^a   Petersen, Finn Bo ^a   Stewart, Patricia S ^a   Storb, Rainer F ^a   Sullivan, Keith M ^a   Tesler, Michele C ^a   Witherspoon, Robert P ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

BONE MARROW TRANSPLANTATION; CONFERENCE PAPER; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMAN; RETROSPECTIVE STUDIES; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS; TISSUE DONORS;

EID: 0025978290     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199102000-00034     Document Type: Article

References (40)

1. Goldman JM, Apperley JF, Jones L, et al. Bone marrow transplantation for patients with chronic myeloid leukemia. N Engl J Med 1986; 314: 202.
2. Appelbaum FR, Storb R, Ramberg RE, et al. Treatment of preleu kemic syndromes with marrow transplantation. Blood 1987; 69: 92.
3. Appelbaum FR, Fisher LD, Thomas ED. Chemotherapy versus marrow transplantation for adults with acute nonlymphocytic leukemia: a five year follow-up. Blood 1988; 72: 179.
4. Welch HG, Larson EB. Cost effectiveness of bone marrow transplantation in acute nonlymphocytic leukemia. N Engl J Med 1989; 321: 807.
5. Appelbaum FR, Hewlett J, Kopecky K, Angle C, Coltman C. Prospective comparative study of bone marrow transplantation versus continued chemotherapy for adult acute nonlymphocytic leukemia: a Southwest Oncology Group study. Blood 1986; 68: 216a.
6. Nesbit M, Buckley J, Lampkin B, et al. Comparison of allogeneic bone marrow transplantation with maintenance chemotherapy in previously untreated childhood acute non-lymphocytic leuke-mia. ASCO Proc 1987; 6: 640a.
7. Beatty PG, Clift RA, Mickelson EM, et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985; 313: 765.
8. Hansen JA, Clift RA, Thomas ED, Buckner CD, Storb R, Giblett ER. Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N Engl J Med 1980; 303: 565.
9. Beatty PG, Ash R, Hows JM, McGlave PB. The use of unrelated bone marrow donors in the treatment of patients with chronic myelogenous leukemia: experience of four marrow transplant centers. Bone Marrow Transplant 1989; 4: 287.
10. Gingrich RD, Ginder GD, Goeken NE, et al. Allogeneic marrow grafting with partially mismatched, unrelated marrow donors. Blood 1988; 71: 1375.
11. Hows JM, Yin JL, March J, et al. Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Blood 1986; 68: 1322.
12. McGlave P, Scott E, Ramsay N, et al. Unrelated donor bone marrow transplantation therapy for chronic myelogenous leukemia. Blood 1987; 70: 877.
13. McCullough J, Rogers G, Dahl R, et al. Development and operation of a program to obtain volunteer bone marrow donors unrelated to the patient. Transfusion 1986; 26: 315.
14. McCullough J, Hansen JA, Perkins H, Stroncek D, Bartsch G. Establishment of the National Bone Marrow Donor Registry. In: Gale R, Champlin R, eds. Bone marrow transplantation: current controversies. New York: Liss, 1989: 641. (New series, vol. 91.)
15. NIH lymphocyte microcytotoxicity technique. In: NIAID manual of tissue typing techniques. Atlanta: National Institute of Allergy and Infectious Disease, 1979: 39 (DHEW publication No. (NIH) 80-545.)
16. Bodmer WF, Albert E, Bodmer JF, et al. Nomenclature for factors of the HLA system 1984. In: Albert ED, Baur MP, Mayr WR, eds. Histocompatibility testing 1984. Berlin: Springer, 1984: 4.
17. Bodmer WF, Albert E, Bodmer JG, et al. Nomenclature for factors of the HLA system 1987. In: Dupont B, ed. Histocompatibility testing 1987. Immunobiology of HLA, vol. 1. New York: Springer, 1989: 72.
18. Danilovs JA, Ayoub G, Terasaki PI. B lymphocyte isolation by thrombin-nylon wool. In: Terasaki PI, ed. Histocompatibility testing 1980. Los Angeles: UCLA Press, 1980: 287.
19. Amos DB. Cytotoxicity testing. In: NIAID manual of tissue typing techniques. Atlanta: National Institute of Allergy and Infectious Diseases, 1979: 42. (DHEW publication No. (NIH) 80-545.)
20. Johnson AH. Antiglobulin microcytotoxicity test. In: NIAID manual of tissue typing techniques. Atlanta: National Institute of Allergy and Infectious Diseases, 1979: 178. (DHEW publication No. (NIH) 80-545.)
21. Hansen JA, Mickelson EM, Beatty PG, Thomas ED. Clinical bonemarrow transplantation: donor selection and recipient monitoring. In: Rose N, Friedman H, Fahey J, eds. Manual of clinical laboratory immunology. 3rd ed. Washington, D.C.: American Society for Microbiology, 1986: 892.
22. Dupont B, Braun DW, Yunis EF, Carpenter CB. HLA-D by cellular typing. In: Terasaki PI, ed. Histocompatibility testing 1980. Los Angeles: UCLA Press, 1980: 229.
23. Beatty PG, Hansen JA, Anasetti C, et al. Marrow transplantation from unrelated HLA-matched volunteer donors. Transplant Proc 1989; 21: 2993.
24. Bearman SI, Appelbaum FR, Buckner CD, et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6: 1562.
25. Storb R, Deeg HJ, Whitehead J, et al. Methotrexate and cyclo sporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314: 729.
26. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295.
27. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457.
28. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: Wiley, 1980.
29. Van Rood JJ, Van Leeuwen A, Goulmy E, et al. The importance of non-HLA systems and the feasibility of the use of unrelated donors in bone marrow transplantation. Transplant Proc 1978; 10: 45.
30. Sprent J, Korngold R. Immunogenetics of graft-versus-host reactions to minor histocompatibility antigens. Immunol Today 1981; 2: 189.
31. Goulmy E. Minor histocompatibility antigens in man and their role in transplantation. In: Morris PJ, Tilney NL, eds. Transplant reviews, vol. 2. Philadelphia: Saunders, 1988: 29.
32. Biddison WE, Krangel MS, Strominger JL, Ward FE, Shearer GM, Shaw S. Virus-immune cytotoxic T-cells recognize structural differences between serologically indistinguishable HLA-A2 mol-ecules. Hum Immunol 1980; 3: 225.
33. Choo SY, Antonelli P, Nisperos B, Nepom GT, Hansen JA. Six variants of HLA-B27 identified by isoelectric focusing. Immunogenetics 1986; 23: 24.
34. Beatty PG, Layrisse Z, Van Seventer GA, et al. T-cell recognition of HLA class I molecules. In: Dupont B, ed. Histocompatibility testing 1987. (Immunobiology of HLA, vol. 1.) New York: Sprin-ger, 1989: 359.
35. Dill O, Kievits F, Koch S, Ivanyi P, Hammerling GJ. Immunologic function of HLA-C antigens in HLA-Cw3 transgenic mice. Proc Natl Acad Sci USA 1988; 85: 5664.
36. Koller B, Geraghty D, Shimizu Y, Demars R, Orr H. A novel HLA class I gene expressed on resting T lymphocytes. J Immunol 1988; 141: 897.
37. Odum N, Peterson CM, Jakobsen BK, et al. HLA-DP and acute graft versus host disease. In: Dupont B, ed. Immunogenetics and histocompatibility. (Immunobiology of HLA, vol. 2.) New York: Springer, 1989: 517.
38. Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED. Antileukemic effect of chronic graft-versus-host disease. N Engl J Med 1981; 304: 1529.
39. Thomas ED, Clift RA. Indications for marrow transplantation in chronic myelogenous leukemia. Blood 1989; 73: 861.
40. Beatty PG, Dahlberg S, Mickelson EM, et al. Probability of finding HLA-matched unrelated marrow donors. Transplantation 1988; 45: 714.